Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Recherche avancée dans les brevets | Images de page | Historique Web | Connexion

Brevets

  

United States Patent [19] [n] Patent Number: 4,742,003

Derynck et al. [45] Date of Patent: May 3, 1988

[54] HUMAN TRANSFORMING GROWTH FACTOR

[75] Inventors: Rik M. A. Derynck, Burlingame;

David V. Goeddel, Hillsborough,
both of Calif.

[73] Assignee: Genentech, Inc., South San
Francisco, Calif.

[21] Appl. No.: 695,494

[22] Filed: May 14, 1985

Related U.S. Application Data

[63] Continuation-in-part of Ser. No. 581,743, Feb. 17, 1984, abandoned.

[51] Int. CI.* C12P 21/00; C12P 21/02;

C12N 15/00; C12N 1/00

[52] U.S. CI 435/68; 435/70

435/172.3; 435/255; 530/324; 530/350: 530/828; 935/13; 935/28; 935/29; 935/57: 935/47; 935/48

[58] Field of Search 435/68, 172.3, 317,

435/70, 255; 260/112 R, 112 B; 536/27; 935/13, 27, 48, 29, 47, 56, 63, 73, 78; 514/12, 2;

530/324, 350, 828

[56] References Cited

U.S. PATENT DOCUMENTS

4,338,397 7/1982 Gilbert et al 435/68

4,358,586 11/1982 Rubin 536/27

4,511,503 4/1985 Olsen et al 260/112 R

4,546,082 10/1985 Kurjan et al 435/172.3

OTHER PUBLICATIONS

Itakura et al., Science, vol. 198, pp. 1056-1063, 1977, "Expression in Escherichia coli of a Chemically Synthesized Gene for the Hormone Somatostatin". Derynck et al., Cell, vol. 38 (1), pp. 287-297, Aug. 1984, "Human Transformig Growth Factor-Alpha: Precursor Structure and Expression in E. coli". Derynck et al., Nature, vol. 316, pp. 701-705, 1985, "Human Transforming Growth Factor-beta Complementary DNA Sequence and Expression in Normal and Transformed Cells".

Derynck et al., Cancer Cells, vol. 3, (Growth Factors Transform.), pp. 79-86, "Human Transforming Growth Factor-Alpha: Precursor Sequence, Gene Structure and Heterologous Expression".

Tame et al. Proc. Natl. Acad. Sci., vol. 83 (21), pp. 8082-8086, 1986, "Efficient Synthesis of Human Type

Alpha Transforming Growth Factor: Its Physical and Biological Characterization."

Marguardt et al., Proc. Natl. Acad Sci., vol. 80, pp. 4684-4688, Aug. 1983, "Transforming Growth Factors Produced by Retrovirus Transformed Rodent Fibroblust and Human Melanoma Cells: Amino Acid Sequence Homology with Epidermal Growth Factor. Marguardt et al., J. Biol. Chem., vol. 257 (9), May 10, 1982, pp. 5220-5225, "Human Transforming Growth Factor".

Toduro et al., Proc. Natl. Acad. Sci., vol. 77 (9), pp. 5258-5262, Sep. 1980, "Transforming Growth Factors Produced by Certain Human Tumor Cells: Polypeptides that Interact with Epidermal Growth Factor Receptors."

Anzano et al., Proc. Natl. Acad. Sci.,' vol. 80, pp. 6264-6268, Oct. 1983, "Surcoma Growth Factor From Conditioned Medium of Virally Transformed Cells is Composed of both Type a and Type j3 Transforming Growth Factors."

Kemp et al., "P/N.A.S. USA" 78(7): 4520-4524, (Jul. 1981).

Taniguchi et al., "P.N.A.S. USA" 77(9): 5230-5233,
(Sep. 1980).

Maniatis, T., "Molecular Cloning, A Laboratory Man-
ual" Cold Springs Harbor Lab., Summary 433, (1982).
Roberts, T. M., "Promoters, Structure & Function"
Rodriguez et al., Ed. 452-461, (1982).
Ohsuye, K., et al., "Nucl. Acids Res." 11(5): 1283-1295,

(1983) .

Kadonaga, J., et al., "J. Biol. Chem." 259(4): 2149-2154,

(1984) .

Roberts, A., et al., "P.N.A.S. USA" 77(6): 3494-3498, (Jun. 1980).

Sporn, M., et al., "Molecular Actions and Targets for
Cancer Chemotherapeutic Agents" Sartorelli, A., et al.,
Ed. 542-554, (1981).

Primary Examiner—Thomas G. Wiseman
Assistant Examiner—Robin Lyn Teskin

[blocks in formation]
[merged small][merged small][merged small][merged small][table]

ala asp pro pro val ala ala ala VAL VAL GAT CTG AGC CCT GCA TCT TTC CTC TCC CCA GCA GAC CCG CCC GTG GCT GCA GCA GTG GTG

Sau3AI PstI

SER HIS PHE ASN ASP CYS PRO ASP SER HIS THR GLN PHE CYS PHE HIS GLY THR CYS ARG
TCC CAT TTT AAT GAC TGC CCA GAT TCC CAC ACT CAG TTC TGC TTC CAT GGA ACC TGC AGG

1 t f

{ Ncol PstI

PHE LEU VAL GLN GLU ASP LYS PRO ALA CYS VAL OC

TTT TTG GTG CAG GAG GAC AAG CCA GCA TGT GTG TAA GTA TCC CCT GTT CTC CTG GAG ATC

Bg^lII

1 10
Met Val Pro Ser Ala Gly Gin Leu Ala Leu Phe Ala Leu Gly lie Val Leu Ala
GGGGGGGGGGGGAGGCTGGAGAGCCTGCTGCCCGCCCGCCCGTAAA ATG GTC CCC TCG GCT GGA CAG CTC GCC CTG TTC GCT CTG GGT ATT GTG TTG GCT
I 50

20 30 -40

Ala Cys Gin Ala Leu Glu Asn Ser Thr Ser Pro Leu Ser Ala Asp Pro Por Val Ala Ala Ala[Val Val Ser His Phe Asn Asp Cys Pro
GCG IGC CAG GCC TTG GAG AAC AGC ACG TCC CCG CTG AGT GCA GAC CCG CCC GTG GCT GCA.GCA GTG GTG TCC CAT TTT AAT GAC TGC CCA
100 [ 150

Pst 1

50 60 70

Asp Ser His Thr Gin Phe Cys Phe His Gly Thr Cys Arg Phe Leu Val Gin Glu Asp Lys Pro Ala Cys Val Cys His Ser Gly Tyr Val
GAT TCC CAC ACT CAG TTC TGC TTC CAT GGA ACC TGC AGG TTT TTG GTG CAG GAG GAC AAG CCA GCA TGT GTC TGC CAT TCT GGG TAC GTT

200| | 250

Nco 1 Pst 1

80 90 100

Gly Ala Arq Cys Glu His Ala Asp Leu Leu Ala| Val Val Ala Ala Ser Gin Lys Lys Gin Ala lie Thr Ala Leu Val Val Val Ser He
GGT GCA CGC TGT GAG CAT GCG GAC CTC CTG GCC GTG GTG GCT GCC AGC CAG AAG AAG CAG GCC ATC ACC GCC TTG GTG GTG GTC TTC ATC

300 350
110 120 130

Val Ala Leu Ala Val Leu lie He Thr Cys Val Leu He His Cys Cys Gin Val Arg Lys His Cys Glu Trp Cys arg Ala Leu He Cys
GTG GCC CTG GCT GTC CTT ATC ATC ACA TGT GTG CTG ATA CAC TGC TGC CAG GTC CGA AAA CAC TGT GAG TGG TGC CGG GCC CTC ATC TGC

400

140 150 160 *

Arg His Glu Lys Pro Ser Ala Leu Leu Lys Gly Arg Thr Ala Cys Cys His Ser Glu Thr Val Val OP

CGG CAC GAG AAG CCC AGC GCC CTC CTG AAG GGA AGA ACC GCT TGC TGC CAC TCA GAA ACA GTG GTC TGA AGAGCCCAGAGGAGGAGTTTGGCCAGG
450 500

TGGACTGTGGCAGATCAATAAAGAAAGGCTTCTTCAGGACAGCACTGCCAGAGATGCCTGGGTGTGCCACAGACCTTCCTACTTGGCCTGTMTCACCTGTGCAGCCTTTTGTGGGCCT
550 600 650

TCAAAACTCTGTCAAGMCTCCGTCGGCTTGGGGTTATTC.GTGTGACCTAGAGAAGAAATCAGCGGACCACGATTTCMGACTTGTTAAAAAAGAACTGCAAAGAGACGGACTCCTGT

700 Nco 1 7 50

TCACCTAGGTGAGGTGTGTGCAGCAGTTGGTGTCTGAGTCLACATGTGTGCAGTTGTCTTCTGCCAGCCATGGATTCCAGGCCSTCCCCCCCCCCCCCCCCCCC FiQ J 800 850

« PrécédentContinuer »